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Japanese encephalitis virus (JEV) is the most prevalent cause of viral encephalitis in
Asia and the western Pacific. Neuronal death caused by JEV infection and inflammation
induced cytotoxicity leads to progression and deterioration of Japanese encephalitis
(JE). Mixed-lineage kinase domain-like protein (MLKL) mediated necroptosis is a newly
discovered pathway of programmed cell death and participates in many inflammatory
diseases. In this study, we demonstrated for the first time that necroptosis was involved
in the neuronal loss during JE via immune-electron microscopy and immunochemistry.
The expression of MLKL in neurons was upregulated in presence of JEV infection in vitro
and in vivo. Deletion of MLKL alleviated the progression of JE and decreased the level of
inflammatory cytokines in mice model. Taken together, this study provides evidence for
the participation of necroptosis in the pathogenesis of JEV infection.
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INTRODUCTION
Japanese encephalitis virus (JEV) is the most prevalent cause of viral encephalitis worldwide. More
than 67,900 cases of JE are reported annually, among which approximately 30% are fatal and 50%
suffer from permanent neuropsychiatric sequelae (Wang and Liang, 2015). JEV infection causes
devastating and fatal neuroinflammation characterized by neuronal destruction accompanied with
intense microgliosis, strogliosis, and production of various inflammatory cytokines (Biswas et al.,
2010; Chen et al., 2010). Neurons can be destroyed directly by JEV infection and indirectly by
inflammation mediated cytotoxicity (Ghoshal et al., 2007; Myint et al., 2014). Then the massive
neuronal death contributes to the progression and deterioration of Japanese encephalitis (JE)
(Myint et al., 2014).
Necroptosis is a newly discovered pathway of programmed cell death (Galluzzi and Kroemer,
2008). Unlike the uncontrolled accidental cell death, necroptosis is regulated by classical necrosome
comprising receptor-interacting protein kinase 1 (RIPK1), RIPK3, mixed-lineage kinase domain-
like protein (MLKL) through TNF/TNFR1 signaling or other stimuli (Vandenabeele et al., 2010;
Sun et al., 2012; Vanden et al., 2014). In addition, DNA-dependent activator of IFN regulatory
factors (DAI) is also identified to induce the RIPK1-independent RIPK3-dependent necroptosis by
recognizing viral double-stranded DNA and recruiting RIPK3 directly through the RHIM domain
(Upton et al., 2012; Sridharan and Upton, 2014; Kuriakose et al., 2016). MLKL is the executor of
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necroptosis after being recruited and phosphorylated by RIPK3.
MLKL recruits Ca2+ and Na+ ion channels and form pores
at the plasma membrane, leading to the rupture of cells. (Cai
et al., 2014; Dondelinger et al., 2014; Wang et al., 2014). Massive
damage-associated molecular patterns (DAMPs) released from
the disintegrated cells trigger inflammatory response (Kaczmarek
et al., 2013). Overproduction of inflammatory cytokines (e.g.,
TNF-α) from activated microglia exposed to DAMPs may induce
more cell death which forms the vicious cycle of necroptosis-
induced inflammation (Pasparakis and Vandenabeele, 2015).
Previous studies have identified that apoptosis and autophagy
are involved in the neuronal loss of JE, which are reported to
be effective intervention targets to alleviate the progression of
JE (Sharma et al., 2014; Lyoo et al., 2015; Huang et al., 2016).
Besides, massive neuronal necrosis is also observed in the human
fatal cases and animal models of JEV infection. During JE, TNF-
α is the main culprit in the neurotoxic cascade and provokes
glial activation as well as subsequent neuroinflammation (Chen
et al., 2012). Interestingly, TNF-α is just the classical initiator
of necroptosis through TNF-α/TNFR1/RIPK1/RIPK3/MLKL
signaling in many central nervous system (CNS) diseases (Cai
et al., 2014; Wang et al., 2014). Necroptosis was also reported to
be activated during viral infection such as herpes simplex virus
(HSV), influenza A virus (IAV) and murine cytomegalovirus
(MCMV) by death cytokines such as TNF or virus itself (Upton
et al., 2012; Huang et al., 2015; Kuriakose et al., 2016). However,
it is still unknown whether necroptosis was involved in the
development of JE. In this study, we found that MLKL mediated
necroptosis was activated in JE and MLKL deleted mice showed
ameliorated progression of JE compared with wild mice. Taken
together, this study provides direct evidence for the roles of
necroptosis in the pathogenesis of JEV infection.
MATERIALS AND METHODS
Ethics Statement
All animal experiments were approved by the Animal Care and
Use Committee of the Fourth Military Medical University.
MLKL−/− Mice
The MLKL+/− C57BL/6 mice were kind gifts from Professor
Jiahuai Han and Dr. Jianfeng Wu (State Key Laboratory of
Cellular Stress Biology and School of Life Sciences, Xiamen
University) and were kept in a specific pathogen-free (SPF)
facility. New-born mice toe DNA samples were amplified
through PCR with PrimeStar (Takara, Japan) and the products
were analyzed by agarose gel electrophoresis for the screening
of WT, MLKL+/−, MLKL−/− descendants (Wu et al., 2013). To
build the JEV infected models, Wild and MLKL−/− mice (4–
6 W) were administered with JEV 5 × 107 PFU/20 g in 200
µl phosphate buffered saline (PBS) intraperitoneally. For the
control, 200 µl PBS was injected intraperitoneally.
Cells and Virus
JEV SA-14 strain was propagated in the mosquito cell line C6/36.
The supernatant containing JEV was concentrated as follows,
the supernatant of JEV-infected C6/36 cell was collected and
centrifuged at 8,000 g for 30 min at 4◦C to remove the cell
debris. Next, the supernatant was ultra-centrifuged at 40,000 g
for 4 h at 4◦C and the viral pellet was resuspended with PBS at
100:1 (supernatant: suspension) after removing the supernatant
thoroughly. After being filtered through 0.22 µm filters, the virus
suspension was titrated by conventional plaque assay and stored
at−80◦C (Lee et al., 2014).
The neuroblast cell line Neuro2a was bought from ATCC and
kept in DMEM (Gibco, Grand Island, NY, USA) containing 10%
fetal bovine serum (FBS, Gibco, Grand Island, NY, USA).
Immuno-Electron Microscopy
The immune-electron microscopy was performed as described
(Fan et al., 2016). Briefly, at 5 days post infection (dpi), mice
were anesthetized with 2% pentobarbital sodium (0.1 ml/10 g
body weight) and perfused with 0.01 M PBS followed by 4%
paraformaldehyde (PFA) containing 0.05% glutaraldehyde for 30
min. The brains were removed and fixed in the 4% PFA for 3 h.
Tissue sections of 50 µm were prepared with a vibratome and
cryoprotected by 30% sucrose. After one freeze-thaw treatment,
the sections were blocked with 5% bovine serum albumin (BSA)
and 5% normal goat serum for 4 h, then incubated with anti-
MLKL antibody (Merck Millipore, Billerica, MA, USA) for 24
h, after rinsed thoroughly and then incubated with goat anti-rat
IgG conjugated to 1.4 nm gold particles (1:100, Nanoprobes) at
room temperature (RT) overnight. After rinsing three times, the
sections were fixed with 2% glutaraldehyde for 45 min. Silver
enhancement was performed in the dark with an HQ Silver
Kit (Nanoprobes) for 15 min. The sections were further fixed
with 0.5% osmium tetroxide, dehydrated with graded ethanol,
replaced with propylene oxide, and flat-embedded in Epon
812. The MLKL-immunoreactive areas were selected, trimmed
under a stereomicroscope and mounted onto blank resin stubs
for ultrathin sectioning. Ultrathin sections (70–80 nm) were
prepared on an LKB Nova Ultratome (Bromma). After being
counterstained with uranyl acetate and lead citrate, the sections
were examined under a JEM-1230 electron microscope (JEM,
Japan).
Propidium Iodide (PI) Staining In vivo
PI (4 mg/ml, Sigma, St. Louis, MO, USA) was prepared in 0.9%
NaCl. At 5 dpi, mice were administered with PI intraperitoneally
(100 µl/20 g weight). One hour later, mice were anesthetized
with 2% pentobarbital sodium and then perfused with 0.01 M
PBS (50 ml) followed by 4% PFA for 30 min. Protected from
light, the brains were removed and fixed in the 4% PFA for 3
h subsequently cryoprotected by 30% sucrose for 48 h. Brain
sections of 10 µmwere prepared with a vibratome and the nuclei
were counterstained by DAPI (100 ng/ml, Sigma, St. Louis, MO,
USA).
Immunohistochemical Staining (IHC)
At 5 dpi, mice were anesthetized with 2% pentobarbital sodium
and then perfused with 0.01 M PBS followed by 4% PFA for
30 min. The brains were removed and fixed in the 4% PFA
for 3 h subsequently cryoprotected by 30% sucrose for 48 h.
Tissue sections of 10 µm were prepared with a vibratome.
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After being fixed with 4% PFA and blocked with 3% BSA
containing 0.1% Triton X-100, the slides were incubated with
primary antibodies anti-NeuN (abcam, Cambridge, MA, USA),
anti-JEV (prepared in our lab), and anti-MLKL (Millipore,
Billerica, MA, USA) diluted with PBS containing 0.1% Triton
X-100 and 1% BSA for 16 h. After washing, the sections
were incubated with the corresponding secondary antibodies
(see Supplementary Table 1) for 1 h at RT. The nuclei were
counterstained with DAPI, and coverslips were placed on the
samples with 50% glycerol in PBS.
Neuro2a Cells Infection
Neuro2a cells were plated in 24-well plates containing glass
slides at the density of 6 × 104 /well overnight. Then cells were
infected with JEV (MOI = 1). After adsorption for 1 h, the virus
suspension was removed, and fresh DMEM was added. After 24
h, the slides were fixed with 4% PFA for 30 min and blocked with
3% BSA for 1 h. Then IHC was conducted for MLKL and JEV as
above.
Neuro2a cells were plated in 6-well plates at the density of 2
× 105/well in DMEM containing 10% FBS overnight. Then cells
were infected with JEV as above at different MOI (0.1, 1, and 5)
and harvested at different time points (12, 24, 48 h after infection)
for qRT-PCR and western blotting.
qRT- PCR
WT and MLKL−/− mice were euthanatized and perfused with
PBS at 5 dpi, then whole brain of each mouse was harvested and
stored at −80◦C. Total RNA from mouse brains and Neuro2a
cells was extracted with RNAfast1000 (PIONEER, China). The
cDNA was prepared by reverse transcription with the total RNA
as template using the PrimeScript RT reagent Kit (TaKaRa,
Japan), qRT-PCR experiments were carried out using SYBR
Green Real-Time PCR Master Mix (TaKaRa, Japan) according to
the manufacturer’s instructions. Each quantitative PCR reaction
was performed in triplicate and the mean threshold cycle (Ct)
value for each sample was used for data analysis. The level of
mRNA expression was normalized with β-actin. The primers
used in this study are as follows:
JEV (forward, 5′- AGACAAGCAGATCAACCACCATT-3′ and
reverse, 5′- CCCTCCAATAGAGCCAAAGTCC -3′).
TNF-α (forward, 5′- CTGAACTTCGGGGTGATCGGT -3′ and
reverse, 5′-ACGTGGGCTACAGGCTTGTCA-3′).
IFN-γ (forward, 5′- GGCCATCAGCAACATAAGCGT -3′ and
reverse, 5′-TGGGTTGTTGACCTCAAACTTGGC-3′).
CCL-2 (forward, 5′- CAAGAAGGAATGGGTCCAGA -3′ and
reverse, 5′-GCTGAAGACCTTAGGGCAGA-3′).
IL-1β (forward, 5′- TCCAAGAAAGGACGAACATTCG -3′ and
reverse, 5′-TGAGGACATCTCCCACGTCAA-3′).
MLKL (forward, 5′- GGATTGCCCTGAGTTGTTGC -3′ and
reverse, 5′-AACCGCAGACAGTCTCTCCA-3′).
β-actin (forward, 5′- TGACGGGGTCACCCACACTG -3′ and
reverse, 5′-AAGCTGTAGCCGCGCTCGGT-3′).
Western Blotting
Total protein from the brain of each mouse or Neuro2a cells
was extracted with RIPA buffer and quantified using a Protein
Reagent Assay BCA Kit (Thermo, Waltham, MA, USA). Thirty
micrograms of protein from each sample was loaded and
electrophoresed using 10% SDS-PAGE gels and then transferred
onto a polyvinylidene difluoride (PVDF) membrane (Millipore,
Billerica, MA, USA). After being blocked with 3% BSA at
RT for 60 min, the membranes were incubated with primary
antibodies anti-MLKL (Millipore, Billerica, MA, USA), pMLKL
(abcam, Cambridge, MA, USA) and β-actin (Proteintech, China)
overnight at 4◦C. Then, the blots were incubated with secondary
antibody (see Supplementary Table 1) for 2 h at RT. The blots
were visualized using an Infrared Imaging System (Odyssey,
LI-COR, NE Lincoln, USA).
ELISA Assay
Serum was collected from each mouse of each group at 5 dpi. The
level of IL-1β, CCL-2, IFN-γ, and TNF-α was tested with Mouse
ELISA Kit (AMEKO, China) and the absorbance was measured
at 450 nm. The concentration was determined according to the
standard curve.
Statistical Analysis
All statistical analyses used GraphPad Prism version 6.01
software. Statistical differences were determined using the
Student’s t-test. P-values < 0.05 were considered significant (∗P
< 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001).
RESULTS
Nerve Cells Undergo Necrosis during JE in
Mice Model
It is known that JEV infection causes neuronal cell death directly
by JEV infection and indirectly by inflammation mediated
cytotoxicity. Besides apoptosis, neuronal necrosis is also found
in autopsy tissues from human fatal cases (German et al.,
2006). Compared with the orderly disassembly of apoptotic
cells, necrotic cells are disintegrated accompanied with massive
release of DAMPs, which can trigger more serious inflammation
(Kaczmarek et al., 2013). In this study, necrosis was detected in
mice infected with JEV at 5 dpi through PI staining and electron
microscopy. At 5 dpi, massive antigen of JEV was detected
in JEV infected mouse brains (see Supplementary Figure 1).
There were a large number of PI positive cells in the brain
sections of JEV infected mice compared with PBS treated mice
(Figures 1A,B). In the microstructure of brain cells, there were
many cells showing classical necrotic morphology with clumps
of chromatin, swollen mitochondria and plasma membrane
disintegration in JEV infected group (Figure 1C). As a result,
nerve cells underwent massive necrotic cell death in the murine
model of JE.
MLKL Mediated Necroptosis Is Involved in
JE
MLKL is the marker and executor of necroptosis. There was
significantly increased expression of TNF-α after JEV infection
in vivo and in vitro in our study (Supplementary Figure 2),
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FIGURE 1 | Nerve cells undergo necrosis during JE in mice model. C57BL/6 mice were infected i.p. with PBS or JEV 5 × 107 PFU in 200 µl PBS/20 g per
mouse. From 5th dpi, JEV infected mice developed body weight loss and early clinical signs such as piloerection, and physical limitation. Brains from each mouse
were harvested for further experiment at 5 dpi. (A) The representative images of PI staining of brain sections from PBS or JEV administrated mice (200x). (B) The
intensity of PI positively stained cells of each group were analyzed with Image J. (Data represents mean ± SEM. PBS = 2, JEV = 3; 3 sections per mouse, 5 fields per
section, **P < 0.01). (C) Micrographs of normal and JEV infected mouse brain cells. In PBS group, the morphology of brain cells. In JEV infected mice, most of brain
cells showed classical necrotic morphology with clumps of chromatin, swollen mitochondria and plasma membrane disintegration (PBS = 1, JEV = 2).
which was in accordance with previous reports. Since TNF-
α is the classical initiator of necroptosis through TNF-
α/TNFR1/RIPK1/RIPK3/MLKL signaling (Cai et al., 2014; Wang
et al., 2014), we detected the expression of MLKL in mice
brain to identify whether MLKL mediated necroptosis was
involved in JE. The MLKL around the plasma membrane
was obvious in the brain sections of JEV infected mice
while it was invisible in control mice (Figure 2A). Granules
immunostained with anti-MLKL antibody were localized to the
plasma membrane in the cortex of JEV infected mice according
to the immune-electron microscopy (Figure 2B). Meanwhile,
there was increased protein level of MLKL and pMLKL in
JEV infected mice (Figure 2C). The level of MLKL mRNA
was also increased in JEV infected group compared to the
PBS treated mice (Figure 2D). Interestingly, the mice showing
more serious clinical symptoms were detected to be higher in
the level of MLKL mRNA (see Supplementary Figure 3). All
these results demonstrated that MLKL mediated necroptosis was
involved in JE.
Necroptosis of Neurons after JEV Infection
Neuronal death played crucial roles in the pathogenesis of JE.
To test whether necroptosis occurs in the neurons, the double-
staining with MLKL and NeuN (the marker of neurons) was
carried out in mouse brains. As expect, the upregulation of
MLKL were mostly occurred in NeuN-labeling cells (Figure 3A).
This indicated that MLKLmediated necroptosis mainly occurred
in neurons during JEV infection. Meanwhile, there were also
co-localization of JEV andMLKL in the cytoplasm of the neurons
(Figure 3B) which was also observed in the cell line Neuro2a cells
(Figure 4A).
The Expression of MLKL Is Upregulated in
Neurons Infected with JEV
It has been shown that MLKL is a mediator of necroptosis. To
investigate whether the upregulation of MLKL expression
was caused by JEV infection, the immunostaining of
MLKL and JEV in Neuro2a cells was conducted. In
vitro, there was visible increased expression of MLKL in
Neuro2a cells infected with JEV compared with control
(Figure 4A). Furtherly, the expression of MLKL in mRNA
(Figures 4B,C) and protein level (Figures 4D,E) were
upregulated accompanying the increase of JEV infection
time and dose. In summary, JEV infection promoted the
expression of MLKL.
MLKL Deleted Mice Show Alleviated
Progression of JE
To explore the role of MLKL in the progression of JE in
vivo. MLKL knock-out mice were infected with JEV, the
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FIGURE 2 | MLKL mediated necroptosis is involved in JE. Mice were infected i.p. with PBS or JEV 5 × 107 PFU in 200 µl PBS/20 g. At 5 dpi, brains were
harvested for immunochemistry, immunoelectromicroscopy, westeron blot and qRT-PCR. (A) The immunochemistry of MLKL in the brain sections of PBS or JEV
administered mice (x400). There was obvious staining of MLKL around the plasma membrane in the brain sections of JEV infected mice while it was invisible in control
mice. (B) Immuno-electron microscopic study of MLKL. The right panels show magnified regions of the boxed areas. Arrows showed the membrane localization of
MLKL. (C) Western-blotting (upper) and quantitation (down) of protein MLKL and pMLKL in PBS or JEV administrated group. There was increased expression of
protein MLKL and pMLKL in JEV infected group (PBS = 2, JEV = 6, *P < 0.05). (D) The relative level of mRNA MLKL in PBS or JEV treated mice brain via qRT-PCR
at 5 dpi. The data represents the relative mRNA level normalized with β-actin (PBS = 4, JEV = 8). The mRNA MLKL was significantly increased in JEV infected mouse
brains compared with PBS group.
FIGURE 3 | Necroptosis of neurons after JEV infection. The double-staining of MLKL and NeuN as well as the double-staining of JEV and MLKL was conducted
in brain sections from JEV infected mice at 5 dpi. (A) Double-immunostaining of MLKL (green) and NeuN (red) in JEV infected mice. The results were acquired by
confocal laser scanning microscope. The increased expression of MLKL was mainly occurred in neurons. (B) Double-immunostaining of MLKL (green) and JEV (red) in
JEV infected mice. The expression of MLKL was closely correlated with JEV infection.
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FIGURE 4 | The expression of MLKL is upregulated in neurons infected with JEV. The expression of MLKL in Neuro2a cells was detected through
immunofluorescence after JEV infection. Meanwhile, the mRNA level of MLKL and protein level of MLKL and pMLKL in Neuro2a cells were tested through qRT-PCR
and western blotting after JEV infection at different MOI and infection time (The data represents the mean ± SEM for 3 independent experiments, *P < 0.05, **P <
0.01, ***P < 0.001 and ****P < 0.0001). (A) Double-immunostaining of MLKL (green) and JEV (red) in Neuro2a cells treated with DMEM (top) and infected with JEV
MOI = 1, 24 h (bottom). (B) Neuro2a cells were infected with JEV at MOI = 1. And 12, 24, 48 h later, cells were collected for RNA extraction and qRT-PCR. The viral
copies and the level of mRNA MLKL increased as the extension of infection time. (C) Neuro2a cells were infected with JEV at MOI = 0.1, 1, 5 respectively. And 24 h
later, cells were collected for RNA extraction and qRT-PCR. The viral copies and the level of mRNA MLKL increased as the increase of infection dose. (D) Neuro2a
cells were infected with JEV at MOI = 1. And 12, 24, 48 h later, cells were collected for total protein extraction and western-bloting. With the extension of infection
time, the expression of protein MLKL and pMLKL increased. (E) Neuro2a cells were infected with JEV at MOI = 0.1, 1, 5 respectively. And 24 h later, cells were
collected for total protein extraction and western-bloting. The level of protein MLKL and pMLKL increased as the increase of infection dose.
body weight (Figure 5A), behavior scores (Figure 5B),
and survival rate (Figure 5C) were recorded daily from
0 dpi until all the survivors were completely stable.
Although, there was no significant improvement in final
survival rate in MLKL−/− mice compared with wild mice,
MLKL−/− mice showed delayed onset of JE and alleviated
symptoms. Thus, MLKL mediated necroptosis aggravated the
progression of JE.
Frontiers in Microbiology | www.frontiersin.org 6 February 2017 | Volume 8 | Article 303
Bian et al. Necroptosis Accelerates Neuroinflammation during JE
FIGURE 5 | MLKL deleted mice show alleviated progression of JE. Wild and MLKL−/− mice were administered with JEV 5 × 107 PFU/20 g in 200 µl PBS
intraperitoneally. The body weight, behavior scores and survival rate were recorded daily from 0 dpi to 23 dpi when the survivals were completely stable (WT = 12,
MLKL−/− = 16). (A) The weight of each mouse was measured and recorded at 16: 30–17: 00 (the data represents the mean ± SD). Compared with wild mice,
MLKL−/− group showed alleviated weight loss. (B) The behavior score was recorded twice every day according to the scoring criteria (0 = no piloerection, no
restriction of movement, no body stiffening, no hind limb paralysis. 1 = piloerection, no restriction of movement, no body stiffening, no hind limb paralysis. 2 =
piloerection, restriction of movement, no body stiffening, no hind limb paralysis. 3 = piloerection, restriction of movement, body stiffening, no hind limb paralysis. 4 =
piloerection, restriction of movement, body stiffening, hind limb paralysis. 5 = piloerection, restriction of movement, body stiffening, hind limb paralysis, sometimes
tremor even death. And the dead mice were excluded from the cohort and the mean scores of all mice in each group were calculated. The data represent the mean ±
SD). MLKL−/− mice showed slowed onset and progression of JE compared with wild group. (C) The death and survival of mice in each group was recorded and the
data was analyzed and shown as Kaplan–Meier survival curves. Even though there was no significant difference in the final survival rate, MLKL−/− group survived for
longer time than wild group.
MLKL Deleted Mice Show Decreased
Inflammatory Cytokines during JEV
Infection
In the MLKL mediated necroptosis, massive DAMPs released
from the disintegrated cells trigger and accelerate inflammation.
To explore the change of inflammation between wild and
MLKL−/− mice after JEV infection, the level of some
inflammatory cytokines in the serum (Figure 6A) and brain
(Figure 6B) at 5 dpi were tested. There was decreased level of
IL-1β, CCL-2, IFN-γ in the serum of MLKL−/− mice compared
with wild mice. The level of TNF-α also showed decline
to some extent, even though without statistically significant
difference. The expression of CCL-2, IL-1β, IFN-γ, and TNF-
α were decreased in the brains of MLKL−/− mice than wild
mice. The decreased inflammation might contribute to the
alleviated progression of JE. At the same time, the death of
neuron was also diminished in MLKL−/− mice at 5 dpi (see
Supplementary Figure 4). However, there was no significant
difference of the viral load in the brain between MLKL−/− and
wild mice (see Supplementary Figure 5). Thus, MLKL mediated
necroptosis worsened the inflammation during the JEV infection.
DISCUSSION
Neuronal death plays fatal roles in the progression of
neuroinflammation during JEV infection, among which
apoptosis and autophagy have been demonstrated to be
involved in. The neurons can directly undergo apoptosis due
to viral replication or through a bystander mechanism where
overactivation of microglia and astrocytes leads to the release
of numerous proinflammatory cytokines, including TNF-α,
IL-1β, and IL-6 (Swarup et al., 2007). The existence of massive
neuronal necrosis in the human fatal cases and animal models
has also been reported. Recently, it was found that necroptosis
also participated in many CNS diseases (Dhib-Jalbut and
Kalvakolanu, 2015; Ito et al., 2016; Meessen-Pinard et al., 2017).
It can be triggered by the TNF family of cytokines and by
ligands of Toll-like receptors 3 and 4 (Vandenabeele et al.,
2010). However, it is still unclear whether the necroptosis, as
a particular form of necrosis, participates in the pathology of
JE. In this study, we demonstrated for the first time that MLKL
mediated necroptosis was involved in the pathogenesis of JE.
Meanwhile, the expression of MLKL was increased during
JEV infection. MLKL−/− mice showed delayed onset of JE,
alleviated symptoms and decreased neuroinflammation and
proinflammatory cytokines compared with wild mice after JEV
infection.
Currently, the research of necroptosis pathway is mainly
focused on TNF/TNFR/RIPK1/RIPK3/MLKL and RIPK1
independently DAI/RIPK3/MLKL signaling. As reported,
production of TNF-α and stimulation of TLRs participated in
the initiation of MLKL mediated necroptosis (Vandenabeele
et al., 2010). During JEV infection, there is robust production of
TNF-α, which might trigger the necroptosis. Many approaches
have been developed to assess the contribution of necroptosis
in experimental disease models such as detection of micro-
morphological and biochemical features, measurement of MLKL
expression, assessment of phosphorylated MLKL level and so
on, among which MLKL phosphorylation has been used as
a diagnostic biomarker (Jouan-Lanhouet et al., 2014). In this
study, we detected MLKL around the neuron membrane from
JEV-infected mice and the increased expression of MLKL and
pMLKL in JEV infected mice and cells. Meanwhile, the mRNA
level of MLKL was also increased after JEV infection. In general,
we proved the existence of MLKL mediated necroptosis during
JE. Interestingly, we also found that the increased expression
of MLKL was mainly occurred in JEV infected cells in vitro
and in vivo. We speculate that JEV infection might induce the
expression of MLKL and several host factors might promote
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FIGURE 6 | MLKL deleted mice show decreased inflammatory cytokines during JEV infection. The serum and brain from each mice in MLKL−/− and wild
group were collected at 5 dpi, and the main inflammatory cytokines in serum and brain were tested. (A) The level of CCL-2, IL-1β, IFN-γ, TNF-α in the serum of WT or
MLKL−/− mice was detected by ELISA assay kit (WT-PBS = 2, MLKL−/−-PBS = 2, WT-JEV = 9, MLKL−/−-PBS = 9). (B) The expression of CCL-2, IL-1β, IFN-γ,
TNF-α in the brain of WT or MLKL−/− mice was detected by qRT-PCR (WT-PBS = 2, MLKL−/−-PBS = 2, WT-JEV = 9, MLKL−/−-PBS = 9, *P < 0.05, ***P <
0.001).
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the phosphorylation of MLKL at the same time. However, the
exact trigger and signal of MLKL phosphorylation during JEV
infection is still under investigation.
It has been established that necroptosis restricts propagation
and spread of lytic virus such as HSV-1 and IAV by eliminating
the infected cells as well as exaggerating inflammatory response
(Huang et al., 2015; Kuriakose et al., 2016; Nogusa et al.,
2016). While, as reported, there was no significantly difference
in the viral load between WT and necroptosis blocking mice
infected with IAV until 6 dpi (Kuriakose et al., 2016). In
our study, the viral load between wild and MLKL−/− mice
after direct injection 50 PFU JEV into the brains showed no
significant difference (see Supplementary Figure 6) before they
gradually died. Thus, necroptosis alone was not enough to restrict
JEV spread in vivo. Conversely, necroptosis and inflammation
promoted each other and causedmore serious CNS disorders and
death during JE.
JE is characterized with extensive neuroinflammation. Until
now, there is no special or effective therapy but symptomatic
relief and supportive treatment (Misra and Kalita, 2010). The
DAMPs, activated glia, inflammatory cytokines and breakdown
of BBB forming an uncontrolled damaged microenvironment
lead to excessive neuronal death, brain dysfunctions, cerebral
edema and respiratory failure, which is the main cause of death
during JE (Han et al., 2014). Blocking the vicious cycle of
inflammatory damage has been shown to benefit the therapy of
JE (Ye et al., 2014; Li et al., 2015). Recently, necroptosis has
been demonstrated to lead to disruption of cell membranes and
release of cytoplasmic contents which triggers and exacerbates
inflammation response (Silke et al., 2015). Several studies have
shown that suppression of necroptosis can alleviate inflammation
induced injury. Kuriakose et al. (2016) reported that blocking
necroptosis could reduce inflammatory responses and epithelial
damage and protect mice from mortality during IAV infection.
Consistently, in our study, MLKL−/− mice showed delayed onset
of JE and alleviated symptoms compared with wild mice after
JEV infection. It indicated that MLKL mediated necroptosis
aggravated the progression of JE. Although MLKL−/− mice
did not survive from JE totally, we found that MLKL−/− mice
showed decreased level of CCL-2, IL-1β, IFN-γ in brain and
serum compared with wild mice after JEV infection. Thus, the
slowing of JE progression in MLKL−/− mice could be attributed
to the interruption of the vicious cycle of necroptosis-induced
inflammation.
In summary, our study indicated that MLKL mediated
necroptosis was involved in the pathogenesis of JE. Targeting
necroptosis may provide new ways to the development of
novel therapeutic strategies for the treatment of JEV induced
encephalitis.
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Supplementary Figure 1 | Massive antigen of JEV was detected in JEV
infected mouse brains at 5dpi.
Supplementary Figure 2 | The relative expression of mRNA TNF-α after
JEV infection in vivo and in vitro. The brains of mice were harvested at 2, 4, 6
dpi after JEV infection intraperitoneally and the RNA of the whole brain was
extracted and the level of TNF-α was detected through qRT-PCR (PBS = 2, 2 dpi
= 2, 4 dpi = 2, 6 dpi = 4). And Neuro2a cells were collected after JEV infection at
different MOI (0.1, 1, and 5) and infection time (12, 24, and 48 h) for the detection
of TNF-α (The data represent the mean ± SEM for 3 independent experiments).
(A) The expression of TNF-α in mouse brains at 2, 4, 6 dpi after JEV infection. (B)
The expression of TNF-α in Neuro2a cells at 12, 24, 48 h after JEV infection at
MOI = 1. (C) The expression of TNF-α in Neuro2a cells at MOI = 0.1, 1, 5 at 24 h
after JEV infection.
Supplementary Figure 3 | The level of mRNA MLKL was higher in mice
with severe clinical symptoms in wild mice.
Supplementary Figure 4 | At 5 dpi, mice from WT-PBS, MLKL−/−-PBS,
WT-JEV, MLKL−/−-JEV were sacrificed for PI staining. (A) The
representative images of PI staining of brain sections from each group (100x). (B)
The intensity of PI positively stained cells of each group were analyzed with Image
J (Data represents mean ± SEM. WT-PBS = 2, MLKL−/−-PBS = 2, WT-JEV = 3,
MLKL−/−-JEV = 3, 3 sections per mouse, 5 fields per section).
Supplementary Figure 5 | The relative viral load in the brain of WT or
MLKL−/− mice were detected by qRT-PCR at 5 dpi after administration
with JEV 5 × 107 PFU/20g in 200 µl PBS intraperitoneally (WT-JEV = 9,
MLKL−/−-JEV = 9).
Supplementary Figure 6 | The relative viral load in the brains of WT or
MLKL−/− mice after injection 50 PFU JEV into the brains. Mice were
anesthetized with 2% pentobarbital sodium (0.05ml/10 g body weight) and
transferred to a stereotaxic apparatus (Stoelting Co, Wood Dale, IL, USA). Then
50 PFU of virus in 2 µl PBS was injected into the right cerebral cortex about 2mm
below the dura through a 5-µL microsyringe (Gaoge China). At 2, 4, 6 dpi, brains
of each group were harvested and the relative viral load in the brain was detected
by qRT-PCR (2 dpi WT-JEV = 4, MLKL−/−-JEV = 4; 4 dpi WT-JEV = 4,
MLKL−/−-JEV = 4; 6 dpi WT-JEV = 6, MLKL−/−-JEV = 7).
Supplementary Table 1 | The antibodies used in this study. For IHC, the
primary antibodies were diluted with 0.01 M PBS containing 0.1% Triton X-100
and 1% bovine serum albumin (BSA). For WB, the primary antibodies were diluted
with 0.01M PBS containing 3% BSA.
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